Gain a global perspective on the lessons learned across Biopharma, MedTech and Healthcare businesses around the world.
________________________________________
Join Biopharma, MedTech and Healthcare industry experts and key opinion leaders as they share their experiences and insights on the lessons learned to date during the COVID-19 pandemic.
For 24 hours, subject-matter experts will give you an-exclusive view into how our industries have responded and adapted to COVID-19 across a series of webinars, fireside chats, round tables, panels and more. Join live on the day and you’ll get the opportunity to ask your burning questions and gain critical insights into today’s landscape and understand the implications for tomorrow’s markets.
Lessons learned during COVID-19
The outbreak and spread of the COVID-19 coronavirus has caused major shifts in how many aspects of the Biopharma, MedTech and healthcare industries are run. Join Informa Pharma Intelligence for a series of wide-ranging, interactive discussions of the lessons learned so far during the outbreak.
Insights from industry leaders and experts
- Hear from industry leaders on how COVID-19 has affected their businesses, what resulting changes may remain post-pandemic, and what the post-COVID-19 commercial landscape may look like
- Get the latest insights on how Biopharma and MedTech industries have evolved as a result of COVID-19, and the steps taken to innovate and adapt to the ripple effects of the pandemic
- Take a deep dive into COVID-19 vaccines – their current status and next steps –as well as pricing and market access issues
- Find out what we can learn from the healthcare professionals battling the pandemic on the front lines, and where we’re at with vaccines and treatments for COVID-19
- Gain a global perspective on the impacts and responses from Biopharma and MedTech businesses around the world
Agenda
Times
Topic
LONDON
NEW YORK
JAPAN
9:00 AM
4:00 AM
5:00 PM
Evolution of Biopharma R&D Through COVID-19
10:00 AM
5:00 AM
6:00 PM
COVID-19: Will it ever again be business as usual for the Medtech Industry?
11:00 AM
6:00 AM
7:00 PM
Custom COVID-19 Dashboard Demo
12:00 PM
7:00 AM
8:00 PM
Development at the speed of light: Pharma’s search for a COVID-19 vaccine
1:00 PM
8:00 AM
9:00 PM
Update from the Front Lines: What challenges and opportunities have global HCP’s identified
2:00 PM
9:00 AM
10:00 PM
Is COVID-19 Good Or Bad For Pharma?
3:00 PM
10:00 AM
11:00 PM
COVID-19 Vaccines: Biopharma’s Rapid Response & Lessons For The Long-Term
4:00 PM
11:00 AM
12:00 AM
How COVID-19 is Changing Healthcare Delivery
5:00 PM
12:00 PM
1:00 AM
Pricing of COVID-19 drugs and therapeutics
6:00 PM
1:00 PM
2:00 AM
From Preclinical Candidate To The Clinic: How Theravance Biopharma Urgently Responded To A Global Pandemic – Sponsored by Theravance
7:00 PM
2:00 PM
3:00 AM
Virtual Drug GMP Inspections
8:00 PM
3:00 PM
4:00 AM
How To Work With The US FDA When You Can’t Meet With Them
9:00 PM
4:00 PM
5:00 AM
How Much Data Is Enough To Approve A COVID-19 Vaccine?
10:00 PM
5:00 PM
6:00 AM
The Future Of Clinical Trials From The Investigator Perspective – Sponsored by CMIC
11:00 PM
6:00 PM
7:00 AM
Coronavirus TV: The Early Days
12:00 AM
7:00 PM
8:00 AM
Coronavirus TV: Developments In Treatment
1:00 AM
8:00 PM
9:00 AM
Coronavirus TV: Vaccines
2:00 AM
9:00 PM
10:00 AM
Coronavirus TV: The Bigger Picture
3:00 AM
10:00 PM
11:00 AM
Decentralized Clinical Trials In 2020: A Global Survey – Sponsored by Clinical Trials Europe
4:00 AM
11:00 PM
12:00 PM
Developing a COVID-19 Treatment In China
5:00 AM
12:00 AM
1:00 PM
Custom COVID-19 Dashboard Demo
6:00 AM
1:00 AM
2:00 PM
Coronavirus Pharma Industry Impact in China, Korea and Japan
7:00 AM
2:00 AM
3:00 PM
India Supply Chain Issues Against the Backdrop of COVID-19
8:00 AM
3:00 AM
4:00 PM
How Has The Pandemic Affected Business Activity In China?